← Wednesday 28 Octobernote 4 of 10
Health researchWed 28 Oct 2026 · 4 of 10

Cochrane review finds workplace ergonomics offer little benefit for CANS

Verified · 5/5 supported1 cited · 1 min read

Medical Xpress reports that an updated Cochrane review found ergonomic interventions show no meaningful benefit for pain, function, recovery or sick leave in workers with work‑related arm, neck or shoulder complaints (CANS) compared with no treatment . Medical Xpress reports that the review analyzed 20 trials involving 2,478 people with work‑related CANS, of which 16 examined nonspecific CANS and included many computer‑using workers . Medical Xpress reports that workplaces invest heavily in ergonomic measures such as office furniture changes and biomechanical or ergonomic education to help office workers with CANS . Medical Xpress reports that CANS disorders develop from repetitive movements, awkward postures or external forces and significantly affect working populations worldwide .

Why it matters. Medical Xpress notes that the findings imply ergonomic programs may make little to no difference for affected workers .

Earlier on Health research

Tue 27 Oct 2026Heme shown to inhibit clot‑dissolving enzyme, study findsMedical Xpress reports that heme, a component of hemoglobin, can inhibit the enzyme plasmin that helps dissolve blood clots. Medical Xpress reports that the research was conducted by a team at the University of Koblenz led by Prof. Dr. Marie‑T. Hopp. Medical Xpress reports that the findings were published in the International Journal of Biological Macromolecules. Medical Xpress reports that the study provides a new molecular approach to understand the link between hemolysis and an increased risk of thrombosis.Mon 26 Oct 2026Bispecific ADC doubles PFS in HR+/HER2‑ breast cancerClinical Trials Arena reports that an $8.4bn bispecific ADC doubles progression‑free survival in HR+/HER2‑ breast cancer. Clinical Trials Arena reports that bispecific ADCs are viewed as the next generation of ADC development. Clinical Trials Arena reports that they continue to be the focus of high‑value dealmaking.Sun 25 Oct 2026Johns Hopkins APL's OsteoSEE Wins R&D 100 Award for Early Fracture DetectionMedical Xpress reports that researchers at Johns Hopkins Applied Physics Laboratory have developed Osteo Surface Echo Evaluation (OsteoSEE), a noninvasive ultrasound-based platform that uses surface acoustic waves to detect microstructural changes and early-stage tibial stress fractures. Medical Xpress reports that OsteoSEE avoids the use of ionizing radiation in fracture detection. Medical Xpress reports that the technology was named a 2026 R&D 100 Award winner. Medical Xpress reports that Anna Knight, the principal investigator, highlighted the platform's potential to support military readiness by enabling earlier detection of common overuse injuries in personnel.
Next · Formula 1Alpine lets Sky Sports commentator give on‑track instructions to Gasly at US GP practice →